CN101822799A - 用于治疗腹泻的中药组合物、制剂及其制备方法 - Google Patents
用于治疗腹泻的中药组合物、制剂及其制备方法 Download PDFInfo
- Publication number
- CN101822799A CN101822799A CN 201010186824 CN201010186824A CN101822799A CN 101822799 A CN101822799 A CN 101822799A CN 201010186824 CN201010186824 CN 201010186824 CN 201010186824 A CN201010186824 A CN 201010186824A CN 101822799 A CN101822799 A CN 101822799A
- Authority
- CN
- China
- Prior art keywords
- extract
- weight portion
- fructus
- preparation
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 238000002360 preparation method Methods 0.000 title claims abstract description 77
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 75
- 239000003814 drug Substances 0.000 title claims abstract description 72
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 215
- 239000000341 volatile oil Substances 0.000 claims abstract description 68
- 238000000034 method Methods 0.000 claims abstract description 56
- 238000001556 precipitation Methods 0.000 claims abstract description 46
- 239000003960 organic solvent Substances 0.000 claims abstract description 37
- 239000008187 granular material Substances 0.000 claims abstract description 15
- 238000000638 solvent extraction Methods 0.000 claims abstract description 15
- 239000002775 capsule Substances 0.000 claims abstract description 11
- 208000019637 Infantile Diarrhea Diseases 0.000 claims abstract description 10
- 238000003809 water extraction Methods 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 125
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 111
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 105
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 75
- 238000003756 stirring Methods 0.000 claims description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 60
- 239000000843 powder Substances 0.000 claims description 58
- 239000000706 filtrate Substances 0.000 claims description 52
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 claims description 30
- 229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 claims description 30
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 26
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 25
- 238000010521 absorption reaction Methods 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 25
- -1 reflux Substances 0.000 claims description 25
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 24
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 24
- 239000012141 concentrate Substances 0.000 claims description 23
- 238000010992 reflux Methods 0.000 claims description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 19
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 19
- 239000002585 base Substances 0.000 claims description 17
- 238000002481 ethanol extraction Methods 0.000 claims description 17
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 17
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 17
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 17
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 17
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 17
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 17
- 239000004299 sodium benzoate Substances 0.000 claims description 17
- 235000010234 sodium benzoate Nutrition 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 16
- 239000003431 cross linking reagent Substances 0.000 claims description 15
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 15
- 239000003623 enhancer Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- 238000012856 packing Methods 0.000 claims description 11
- 239000004745 nonwoven fabric Substances 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 10
- 230000001476 alcoholic effect Effects 0.000 claims description 9
- 230000000741 diarrhetic effect Effects 0.000 claims description 9
- 239000002985 plastic film Substances 0.000 claims description 9
- 229920006255 plastic film Polymers 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 7
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229920003169 water-soluble polymer Polymers 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 3
- 229910021502 aluminium hydroxide Inorganic materials 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 235000008184 Piper nigrum Nutrition 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 235000002566 Capsicum Nutrition 0.000 abstract 2
- 239000006002 Pepper Substances 0.000 abstract 2
- 241000722363 Piper Species 0.000 abstract 2
- 235000016761 Piper aduncum Nutrition 0.000 abstract 2
- 235000017804 Piper guineense Nutrition 0.000 abstract 2
- 238000012360 testing method Methods 0.000 description 36
- 239000000243 solution Substances 0.000 description 34
- 229940075559 piperine Drugs 0.000 description 23
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 22
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 22
- 235000019100 piperine Nutrition 0.000 description 22
- 239000006071 cream Substances 0.000 description 21
- 238000005516 engineering process Methods 0.000 description 20
- 239000012567 medical material Substances 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 230000001142 anti-diarrhea Effects 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 239000013521 mastic Substances 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- 238000000465 moulding Methods 0.000 description 10
- 239000013558 reference substance Substances 0.000 description 9
- 238000009825 accumulation Methods 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- HYPPXZBJBPSRLK-UHFFFAOYSA-N diphenoxylate Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 HYPPXZBJBPSRLK-UHFFFAOYSA-N 0.000 description 8
- 229960004192 diphenoxylate Drugs 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 7
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 7
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 7
- 239000004744 fabric Substances 0.000 description 7
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 7
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 7
- 229940025878 hesperidin Drugs 0.000 description 7
- 230000008595 infiltration Effects 0.000 description 7
- 238000001764 infiltration Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 7
- 239000012535 impurity Substances 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 230000001186 cumulative effect Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000008485 antagonism Effects 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000011020 pilot scale process Methods 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241001078983 Tetradium ruticarpum Species 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000011003 system suitability test Methods 0.000 description 3
- 244000141331 Amomum villosum Species 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- VBIRCRCPHNUJAS-AFHBHXEDSA-N 4-[(1S,3aR,4S,6aR)-4-(1,3-benzodioxol-5-yl)tetrahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 VBIRCRCPHNUJAS-AFHBHXEDSA-N 0.000 description 1
- 241001571352 Amomum longiligulare Species 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- QHWOFMXDKFORMO-UHFFFAOYSA-N Deltaalphabetadihydropiperine Natural products C=1C=C2OCOC2=CC=1CCC=CC(=O)N1CCCCC1 QHWOFMXDKFORMO-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- QHWOFMXDKFORMO-XVNBXDOJSA-N Piperanine Chemical compound C=1C=C2OCOC2=CC=1CC/C=C/C(=O)N1CCCCC1 QHWOFMXDKFORMO-XVNBXDOJSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 description 1
- AOZUYISQWWJMJC-UHFFFAOYSA-N acetic acid;methanol;hydrate Chemical compound O.OC.CC(O)=O AOZUYISQWWJMJC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229960002028 atropine sulfate Drugs 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- VPSRGTGHZKLTBU-UHFFFAOYSA-N piperitol Natural products COc1ccc(cc1OCC=C(C)C)C2OCC3C2COC3c4ccc5OCOc5c4 VPSRGTGHZKLTBU-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- HPOHAUWWDDPHRS-UHFFFAOYSA-N trans-piperitol Natural products CC(C)C1CCC(C)=CC1O HPOHAUWWDDPHRS-UHFFFAOYSA-N 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101868244A CN101822799B (zh) | 2010-05-26 | 2010-05-26 | 用于治疗腹泻的中药组合物、制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101868244A CN101822799B (zh) | 2010-05-26 | 2010-05-26 | 用于治疗腹泻的中药组合物、制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101822799A true CN101822799A (zh) | 2010-09-08 |
CN101822799B CN101822799B (zh) | 2012-07-25 |
Family
ID=42687104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101868244A Active CN101822799B (zh) | 2010-05-26 | 2010-05-26 | 用于治疗腹泻的中药组合物、制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101822799B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552590A (zh) * | 2011-11-18 | 2012-07-11 | 罗凤莲 | 一种治疗小儿腹泻的药剂 |
CN104587361A (zh) * | 2014-12-25 | 2015-05-06 | 姜新帅 | 一种止泻的中药组合物 |
CN109077349A (zh) * | 2018-08-28 | 2018-12-25 | 河北中烟工业有限责任公司 | 具有抗抑郁功效的组合物及制备工艺以及在电子烟油中的应用 |
CN116270489A (zh) * | 2023-03-22 | 2023-06-23 | 遵义市中医院 | 一种姜功胃安颗粒及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101596249A (zh) * | 2009-07-08 | 2009-12-09 | 成都晟铭医药科技有限公司 | 治疗腹泻的中药组合物和中药药物及其制备方法 |
-
2010
- 2010-05-26 CN CN2010101868244A patent/CN101822799B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101596249A (zh) * | 2009-07-08 | 2009-12-09 | 成都晟铭医药科技有限公司 | 治疗腹泻的中药组合物和中药药物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
《中国中药杂志》 20030531 刘文,孙宇章 胡椒中胡椒碱的提取工艺研究 第456-457页 2-4,12 第28卷, 第5期 2 * |
《农产品加工•学刊》 20090228 刘杰,杨春亮,章程辉,查玉兵,范东翠 胡椒碱的功能及萃取工艺研究进展 第48-51页 1-5,11-12 , 第163期 2 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552590A (zh) * | 2011-11-18 | 2012-07-11 | 罗凤莲 | 一种治疗小儿腹泻的药剂 |
CN102552590B (zh) * | 2011-11-18 | 2013-06-12 | 罗凤莲 | 一种治疗小儿腹泻的药剂 |
CN104587361A (zh) * | 2014-12-25 | 2015-05-06 | 姜新帅 | 一种止泻的中药组合物 |
CN109077349A (zh) * | 2018-08-28 | 2018-12-25 | 河北中烟工业有限责任公司 | 具有抗抑郁功效的组合物及制备工艺以及在电子烟油中的应用 |
CN116270489A (zh) * | 2023-03-22 | 2023-06-23 | 遵义市中医院 | 一种姜功胃安颗粒及其制备方法 |
CN116270489B (zh) * | 2023-03-22 | 2023-09-08 | 遵义市中医院 | 一种姜功胃安颗粒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101822799B (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101297864B (zh) | 夏桑菊制剂的制备方法 | |
CN101822799B (zh) | 用于治疗腹泻的中药组合物、制剂及其制备方法 | |
CN101407557A (zh) | 一种金钗石斛多糖提取物的制备和应用 | |
CN102579860A (zh) | 一种安儿宁提取物组合物及其制备方法和应用 | |
CN103848875A (zh) | 一种龙胆苦苷原料的制备方法 | |
CN1876039B (zh) | 治疗上呼吸道感染等疾病的药物制剂的检测方法 | |
CN101757099B (zh) | 金茵利胆药物及其制备方法和质量控制方法 | |
CN101057890B (zh) | 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 | |
CN102327309B (zh) | 一种小檗皮提取物及该提取物和小檗皮的用途 | |
CN101088553B (zh) | 百部生物碱有效部位及其应用 | |
CN101019891B (zh) | 蟾皮总碱及其制备和分析方法以及其制剂 | |
CN102302615B (zh) | 一种祖师麻叶有效部位群、其制备方法、药物组合物和应用 | |
CN101637550B (zh) | 一种蒲葵子多糖提取物及其制备方法与用途 | |
CN104127510B (zh) | 小儿热速清颗粒矫味组合物及其颗粒剂和制法 | |
CN102258552B (zh) | 一种白芷饮片的制备方法 | |
CN102293889B (zh) | 四磨汤干混悬剂及其制备方法 | |
CN1923264B (zh) | 茵白肝炎胶囊 | |
CN102641252A (zh) | 盐酸特比萘芬固体分散体及其片剂 | |
CN101966218A (zh) | 一种三七三醇组皂苷提取物及其制备工艺 | |
CN103083677A (zh) | 一种透皮促进剂及其在促透中的应用 | |
CN1181836C (zh) | 一种治疗糖尿病的中药组合物 | |
CN102188468B (zh) | 一种心脑舒通片的制备方法 | |
CN114404487B (zh) | 黄根或其提取物在制备用于治疗胶质瘤的药物中的应用 | |
CN103142597B (zh) | 一种吐根有效成分的组合物及其制备方法和应用 | |
CN103656612A (zh) | 海鞘多肽药物组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HENGKANG MEDICAL GROUP CO., LTD. Free format text: FORMER OWNER: CHENGDU SHENGMING PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20140611 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610041 CHENGDU, SICHUAN PROVINCE TO: 746500 LONGNAN, GANSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140611 Address after: 746500 Gansu city of Longnan Province Wang Kang dam Duyiwei Industrial Park Patentee after: HENGKANG MEDICAL GROUP CO.,LTD. Address before: 610041 Building 1, high tech incubator Park, South Tianfu Road, Tianfu Road, Chengdu hi tech Zone, Sichuan Patentee before: CHENGDU SHENGMING PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 746500 Wang Yi Industrial Park, Wang Ba, Kang County, Longnan, Gansu Patentee after: New Journey Health Technology Group Co.,Ltd. Address before: 746500 Wang Yi Industrial Park, Wang Ba, Kang County, Longnan, Gansu Patentee before: HENGKANG MEDICAL GROUP CO.,LTD. |